OtherArticle
GENOTOXICITY OF 2-(3-CHLOROBENZYLOXY)-6-(PIPERAZINYL)PYRAZINE, A NOVEL 5-HT2C RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY: ROLE OF METABOLIC ACTIVATION
Amit S. Kalgutkar, Deepak Dalvie, Jiri Aubrecht, Evan Smith, Stefanie Coffing, Jennifer Cheung, Chandra Vage, Mary Lame, Phoebe Chiang, Kim McClure, Tristan Maurer, Richard Coelho, Victor Soliman and Klaas Schildknegt
Drug Metabolism and Disposition March 7, 2007, DOI: https://doi.org/10.1124/dmd.106.013649
Amit S. Kalgutkar
Deepak Dalvie
Jiri Aubrecht
Evan Smith
Stefanie Coffing
Jennifer Cheung
Chandra Vage
Mary Lame
Phoebe Chiang
Kim McClure
Tristan Maurer
Richard Coelho
Victor Soliman
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
GENOTOXICITY OF 2-(3-CHLOROBENZYLOXY)-6-(PIPERAZINYL)PYRAZINE, A NOVEL 5-HT2C RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY: ROLE OF METABOLIC ACTIVATION
Amit S. Kalgutkar, Deepak Dalvie, Jiri Aubrecht, Evan Smith, Stefanie Coffing, Jennifer Cheung, Chandra Vage, Mary Lame, Phoebe Chiang, Kim McClure, Tristan Maurer, Richard Coelho, Victor Soliman and Klaas Schildknegt
Drug Metabolism and Disposition March 7, 2007, DOI: https://doi.org/10.1124/dmd.106.013649
OtherArticle
GENOTOXICITY OF 2-(3-CHLOROBENZYLOXY)-6-(PIPERAZINYL)PYRAZINE, A NOVEL 5-HT2C RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY: ROLE OF METABOLIC ACTIVATION
Amit S. Kalgutkar, Deepak Dalvie, Jiri Aubrecht, Evan Smith, Stefanie Coffing, Jennifer Cheung, Chandra Vage, Mary Lame, Phoebe Chiang, Kim McClure, Tristan Maurer, Richard Coelho, Victor Soliman and Klaas Schildknegt
Drug Metabolism and Disposition March 7, 2007, DOI: https://doi.org/10.1124/dmd.106.013649
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement